Advisory Alpha’s Colgate-Palmolive CL Stock Holding History

Advisory Alpha’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-364	Closed	-$28K	–	196
2020 Q3	$28K	Buy	+364	New	+$27.8K	0.01%	276
2020 Q2	–	Sell	-371	Closed	-$26.4K	–	170
2020 Q1	$26.4K	Buy	+371	New	+$26.2K	0.01%	280
2019 Q4	–	Sell	-34	Closed	-$2.4K	–	785
2019 Q3	$2.4K	Buy	+34	New	+$2.47K	﹤0.01%	628
2019 Q2	–	Sell	-35	Closed	-$2.48K	–	203
2019 Q1	$2.48K	Buy	+35	New	+$2.26K	﹤0.01%	534

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisory Alpha's CL Position: Q4 2020 in Review

Advisory Alpha sold out of Colgate-Palmolive (CL) in Q4 2020, closing a stake of 364 shares — an estimated $28K sold.

Advisory Alpha first reported a position in CL in Q1 2019 and held it in 4 quarters. The position peaked at $28K in Q3 2020. 1,650 funds tracked by Wall St. Rank hold CL as of Q4 2020.

Advisory Alpha reported no remaining Colgate-Palmolive position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 364 Colgate-Palmolive shares in Q4 2020, an estimated $28K.
Advisory Alpha first reported a position in Colgate-Palmolive in Q1 2019 and held it in 4 quarters.
Advisory Alpha's Colgate-Palmolive position peaked at $28K in Q3 2020.
1,650 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.